|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.6018 - 1.6046|
|52 Week Range||1.0000 - 3.4473|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
OTCPK: ARHH), a provider of intraoperative neuromonitoring services, is pleased to announce that it held its annual general meeting of shareholders (the “Meeting”) earlier today in Denver, Colorado and that all resolutions were overwhelmingly approved by shareholders of the Company. The resolutions included the election of directors, appointment of auditors and the approval of the Company’s stock option plan. The management information circular which further summarizes the resolutions approved at the Meeting are available at www.sedar.com.
DENVER, Nov. 27, 2018 -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, reported financial.
OTC: ARHH), a provider of intraoperative neuromonitoring services, will hold a conference call on Tuesday, November 27, 2018, at 4:30 p.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2018. The company will report its financial results in a press release prior to the conference call. Assure’s Executive Chairman and Interim CEO John Farlinger, CFO Trent Carman and Founder Preston Parsons will host the conference call, followed by a question and answer period.
OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has appointed Scott Page as an advisor to the Company’s board of directors. Page brings over 38 years of commercial banking experience to Assure. Currently, he is president of Lobo Consulting, which provides a variety of consulting services to small and mid-sized companies, including debt and capital structuring, strategic planning and executive coaching.
OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has been invited to present at the Rocky Mountain Microcap Conference III, which is being held on October 9, 2018, at the Ameristar Resort in Black Hawk, CO. For more information about the conference or to schedule a one-on-one meeting with Assure management, please contact your Rocky Mountain Microcap representative, or Assure’s investor relations team at IOM@liolios.com. Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries.
OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announces that it has issued an aggregate of 500,000 options to purchase common shares of the Company (the “Options”) to officers, employees, directors and consultants of the Company. Each of the Options issued will be exercisable at US$1.80 (equivalent to C$2.33, based on the noon exchange rate set by the Bank of Canada on September 28, 2018). 20% of each option issuance will vest immediately and one sixth of the balance will vest every 6 months thereafter.
OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has appointed Trent Carman as chief financial officer, effective October 22nd, 2018. Carman comes to Assure with more than 20 years of CFO experience, including over 15 years of healthcare industry expertise for both public and private organizations. Most recently he served as CFO for Vivos Therapeutics and prior to that was CFO at Air Methods Corp. (formerly Nasdaq: AIRM) for over 13 years.
OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has performed its first neuromonitoring case in the state of Pennsylvania. The move into Pennsylvania represents the fourth new state Assure has added to its platform since branching out from its home state of Colorado just last November. This rapid expansion has been driven by Assure’s scalable neuromonitoring platform, as well as the Company’s strong relationships and focus on service.